Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Mitotaneworks primarily by inhibiting the function of adrenal cortical cells. It can inhibit cholesterol side-chain lyase, a key enzyme in steroid hormone synthesis, thereby reduci···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：439
Mitotaneis a medication used to treat specific types of cancer and adrenal gland-related disorders.What is the recommended dosage of Mitotane?The clinically recommended dose of Mit···【more】
Article source：Captain MedicineRelease date：2024-08-19Recommended：462
Selpercatinib blocks tumor growth and spread by inhibiting the kinase activity of the RET fusion protein. As a targeted drug, it has been used to treat a variety of cancer types as···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：355
Selpercatinib is an innovative RET inhibitor specifically designed to treat cancers associated with RET gene mutations. By interfering with the signaling pathways of cancer cells, ···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：416
Selpercatinib is a highly selective RET inhibitor that inhibits the growth of tumor cells by blocking RET kinase activity. In May 2020, the FDA approved the drug for use as an impo···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：343
Selpercatinib is the first targeted drug specifically targeting RET gene mutations and was approved by the FDA in 2020; By inhibiting the activity of RET kinase and blocking the gr···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：325
In May 2020, Selpercatinib was approved by the FDA for the treatment of various cancers caused by RET gene mutations. The drug stops the spread of the lesion by interfering with th···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：404
Selpercatinib treats cancer patients by specifically inhibiting RET kinase activity. In 2020, it was approved for marketing in United States, becoming the first drug specifically t···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：349
Selpercatinib helps control the proliferation and metastasis of cancer cells by blocking the RET signaling pathway. The drug, which is indicated for patients over 12 years of age, ···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：438
As a highly selective RET inhibitor, Selpercatinib is used for the treatment of RET fusion-positive and mutation-associated cancers. It was approved by the FDA in 2020 and has show···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：372
The commonly used dosage form of Mitotane is a tablet, which is an antineoplastic drug. It is used to treat inoperable adrenocortical tumors. Cushing syndrome can also be treated.W···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：362
Selpercatinib is a targeted drug that specifically targets mutations in the RET gene. By inhibiting RET kinase activity, it prevents the growth and spread of cancer cells. It is su···【more】
Article source：Captain MedicineRelease date：2024-08-16Recommended：367
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
